NCT01958944View on ClinicalTrials.gov

Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Cystic Fibrosis
Interventions
DRUG

Nitric oxide

Trial Locations (2)

49202

Schneider Children's Medical Center of Israel, Petach Tikvah

84101

Soroka university, Beersheba

Sponsors

Lead Sponsor

Beyond Air Inc.
All Listed Sponsors
collaborator

Soroka University Medical Center

OTHER

collaborator

Schneider Children's Medical Center, Israel

OTHER

lead

Beyond Air Inc.

INDUSTRY

NCT01958944 - Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis | Biotech Hunter | Biotech Hunter